These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3449093)

  • 1. Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456).
    Baker DC; Hand ES; Plowman J; Rampal JB; Safavy A; Haugwitz RD; Narayanan VL
    Anticancer Drug Des; 1987 Dec; 2(3):297-309. PubMed ID: 3449093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
    Supko JG; Balcerzak SP; Kraut EH
    Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.
    Dexter DL; Hesson DP; Ardecky RJ; Rao GV; Tippett DL; Dusak BA; Paull KD; Plowman J; DeLarco BM; Narayanan VL
    Cancer Res; 1985 Nov; 45(11 Pt 1):5563-8. PubMed ID: 4053030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compounds with presumable antitumor activity. III. 1-Substituted N,N'-di-2-pyrimidinyl (or pyrazinyl)methylenediamine].
    Chimirri A; Grasso S; Monforte P; Fenech G
    Farmaco Sci; 1984 Sep; 39(9):797-805. PubMed ID: 6500046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and antibacterial and antitumoral activity of some methylhydrazonium salts of pyrimidine bases and their analogues (author's transl)].
    Golovinsky E; Karamanov G; Spassovska N; Maneva L; Spassov A
    Pharmazie; 1982 May; 37(5):355-6. PubMed ID: 7111362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines.
    Suzuki Y; Cluzeau J; Hara T; Hirasawa A; Tsujimoto G; Oishi S; Ohno H; Fujii N
    Arch Pharm (Weinheim); 2008 Sep; 341(9):554-61. PubMed ID: 18763715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of 6-chloro-4-fluoroalkylamino-2-heteroaryl-5-(substituted)phenylpyrimidines as anti-cancer agents.
    Zhang N; Ayral-Kaloustian S; Nguyen T; Hernandez R; Lucas J; Discafani C; Beyer C
    Bioorg Med Chem; 2009 Jan; 17(1):111-8. PubMed ID: 19041247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of pyrazine derivatives. XXI. Synthesis and tuberculostatic activity of 4-aryl-1-pyrazinoylthiosemicarbazides and the products of their cyclization to 1,2,4-triazole-3-thione derivatives].
    Rudnicka W; Foks H; Janowiec M; Zwolska-Kwiek Z
    Acta Pol Pharm; 1986; 43(6):523-8. PubMed ID: 3577832
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas chromatographic assay for the new antitumor agent pyrazine-2-diazohydroxide (diazohydroxide) and its stability in buffer, blood and plasma.
    Wilke TJ; Kooistra KL; Moore DJ; Powis G
    J Chromatogr; 1986 Nov; 383(1):77-83. PubMed ID: 3818847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
    Vogelzang NJ; Mani S; Schilsky RL; Ansari RH; Taber D; Rhinehart SN; Garcia JC; Meyer SC; Mick R; Brockstein BE; Stadler WM; Ratain MJ; Vokes EE
    Clin Cancer Res; 1998 Apr; 4(4):929-34. PubMed ID: 9563886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isothiazolopyrimidines--new group of anticancer agents. I.
    Machoń Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agents.
    Thompson MD; Cupps TL; Wise DS; Wotring LL; Townsend LB
    J Med Chem; 1997 Feb; 40(5):766-70. PubMed ID: 9057863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation.
    Brodfüehrer JI; Moore DJ; Melder DC; Wilke TJ; Powis G
    Invest New Drugs; 1988 Apr; 6(1):3-9. PubMed ID: 3410664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.